Health Topics — Mind, Body & Stress
Seasonal Mood, Winter Light, and the Endocannabinoid System
For the person whose mood, energy, sleep, and appetite shift noticeably as the days shorten — what the research on circadian biology, light exposure, and endocannabinoid tone shows about why this happens and what connects these systems.
It arrives on a schedule. Sometime in October or November the energy begins to drop. Sleep becomes heavier but less restorative. Motivation thins. The appetite shifts toward carbohydrates. A low-grade flatness settles in that is not exactly depression but is not the same as the person who existed in July either.
For many people this pattern is so consistent and predictable that they have come to think of it simply as winter — something to be endured. What the research shows is that it is biology, and biology can be understood and in some cases supported.
What seasonal mood patterns are
Seasonal affective disorder — SAD — is the clinical diagnosis for significant seasonal mood disruption, affecting an estimated 1–3% of the general population with a further 10–20% experiencing a milder version sometimes called subsyndromal SAD or winter blues. The pattern is consistent: mood, energy, and sleep quality decline as photoperiod shortens in autumn and winter and improve as daylight extends in spring. The condition is significantly more prevalent at higher latitudes, confirming that reduced light exposure is the primary driver.
The mechanism involves the suprachiasmatic nucleus — the brain's master circadian clock — which uses light input from the retina to synchronise the body's biological rhythms. When light exposure is reduced and its timing shifts, the circadian system desynchronises from the environmental cycle. Melatonin — which is suppressed by light — is produced for longer periods in winter, shifting its phase relative to sleep and wakefulness. Serotonin synthesis in the brain is reduced with lower light exposure. Dopamine availability falls. The cumulative effect on mood, motivation, energy, and appetite is what the person experiencing winter blues recognises from the inside.
Where the endocannabinoid system connects
The endocannabinoid system is integrated with the circadian system at multiple levels. CB1 receptors are expressed in the suprachiasmatic nucleus itself, and endocannabinoid signalling modulates the circadian clock's output — influencing the timing and amplitude of its signals to downstream systems. Research has documented that endocannabinoid tone varies across the day in a circadian pattern, and that disruption of the circadian system produces measurable changes in endocannabinoid activity.
The serotonin connection is also relevant. CBD's partial agonism at the 5-HT1A serotonin receptor — the same mechanism documented in anxiety and mood research — is directly relevant to the reduced serotonin synthesis that underlies seasonal mood decline. This is not a claim that CBD treats seasonal affective disorder. It is a mechanistic observation that one of CBD's primary documented activities engages the same neurotransmitter system that light-driven seasonal mood patterns disrupt.
The HPA axis and cortisol dynamics add a third connection. Circadian disruption — and winter's longer melatonin phase is a form of circadian disruption — is associated with altered cortisol rhythms. The cortisol awakening response, which should be sharp and well-timed in the early morning, becomes blunted and mistimed in people with circadian disruption. CBG's documented HPA axis modulation and its effect on the stress response are therefore relevant in the seasonal context, not because winter is a stressor in the conventional sense but because the circadian disruption it produces affects the same cortisol regulatory system CBG engages.
What actually helps — and where cannabinoids fit
The most evidence-supported intervention for seasonal mood patterns is light therapy — a 10,000 lux bright light exposure of 20–30 minutes in the morning, which directly addresses the photoentrainment deficit that drives the condition. For significant SAD, this has effect sizes comparable to antidepressant medication in controlled trials. For the milder winter blues pattern, morning light exposure — even natural light from a morning walk — is the single most reliable and accessible intervention.
Vitamin D supplementation is the second most studied intervention. Vitamin D synthesis requires UV-B light exposure, which is absent at most latitudes in winter, and deficiency is common in populations that experience seasonal mood patterns. The relationship between vitamin D and mood is not fully resolved, but supplementation in deficient individuals is associated with improved mood outcomes in some trials.
Cannabinoid preparations sit in the research landscape as a potential supporting element — not a replacement for light therapy, and not a primary intervention for significant SAD. The mechanisms connecting CBD's serotonin receptor activity and CBG's HPA axis modulation to seasonal mood biology are coherent and specific, but no controlled trial of CBD or CBG for seasonal mood patterns exists. The evidence supports a plausible rationale, not a clinical recommendation.
For the person experiencing the milder winter blues pattern — the flatness and low energy that arrives on schedule but does not constitute clinical depression — a cannabinoid preparation used consistently through the winter months is a reasonable supporting measure alongside the established interventions, assessed honestly against the functional markers that matter most to them: sleep quality, morning energy, the degree of the seasonal dip in motivation and mood.
The timing question
When to start is worth considering. The circadian and serotonin disruption that produces winter mood patterns builds gradually as photoperiod shortens — it does not arrive all at once in December. The person who starts a preparation in September or October, as the days begin shortening, is supporting a regulatory system that is still in relatively good shape rather than trying to restore one that has already been significantly depleted. This is a practical consideration, not a marketing one — regulatory systems generally respond better to support during decline than to restoration after significant disruption.
If seasonal mood patterns are significantly affecting your life
Significant seasonal affective disorder — particularly when it involves persistent low mood, withdrawal from relationships, or difficulty functioning at work — is a clinical condition that responds well to established treatments including light therapy, therapy, and where indicated medication. The winter blues pattern described in this article is milder and more diffuse. If you are unsure which category your experience falls into, speaking with a physician or mental health professional is the right first step. Cannabinoid preparations are not a substitute for clinical care for significant seasonal depression.
These statements have not been evaluated by the Food and Drug Administration. J.P. Hemp Company products are not intended to diagnose, treat, cure, or prevent any disease.